Please Wait.....
Report
Vascular Sealing Medical Glue Market By Procedure (Revascularization, Others) , By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 280 Pages I Allied Market Research
The vascular sealing medical glue market was valued at $0.7 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.
Vascular sealing medical glue is a surgical adhesive that possesses high adhesive and hemostatic properties, and is used to seal and reinforce tissues. These adhesives are play a pivotal role in creating functional connections between damaged tissues and between tissues and implanted biomaterials. They are majorly developed to minimize the use of surgical sutures and mechanical methods of tissue fusion, which are useful in conventional surgeries. This is attributed to the fact that vascular sealing glues promote tissue regeneration and healing, mitigate the risk of infection, and minimize tissue trauma as compared to conventional methods. Natural medical adhesives available in the market include fibrin adhesives and collagen-based products, which are highly effective in adhesion.
The growth of the global vascular sealing medical glue market is majorly driven by alarming rise in prevalence of cardiovascular diseases and corresponding increase in need for surgeries, such as angioplasty and coronary artery bypass grafting, are boosting the demand for vascular sealing medical glue. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases and often require procedures to address issues such as varicose veins and atherosclerosis, thus increasing the need for vascular sealing glues. As per the article published by the Revista Espanola de Cardiologia-the official publication of the Spanish Society of Cardiology-coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers due to quicker recovery times and reduced hospital stays fosters the growth of the market. However, safety concerns associated with vascular sealing medical glue hamper the growth of the market. For instance, some adhesives are cytotoxic and are poorly absorbed, which limit their demand in healthcare settings. Furthermore, inability to medical adhesives to provide adequate and immediate seal, increased risk of infection, and delayed healing act as the key deterrent factors of the market. On the contrary, to reduce the risk of infection at the surgical sites, manufacturers are developing vascular sealing medical glue with antimicrobial properties, thus ensuring post-operative care and patient safety. In addition, continuous innovations in the formulation of medical glues to enhance their adhesive strength are expected to offer lucrative opportunities for the expansion of the market during the forecast period.
The global vascular sealing medical glue market is segmented into procedure, end user, and region. By procedure, the market is categorized into revascularization and others. On the basis of end user, it is divided into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
-By procedure, the revascularization segment dominated the market share in 2023.
-On the basis of end user, the hospitals segment exhibited the highest growth in 2023.
-Region wise, North America lead the market in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global vascular sealing medical glue market include Baxter International Inc., Becton, Dickinson and Company, Artivion, Inc., Success Bio-tech, Integra LifeSciences Holdings Corporation, Stryker Corporation, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Procedure
- Revascularization
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Baxter International Inc.
- Becton, Dickinson and Company
- Artivion, Inc.
- Success Bio-tech
- Integra LifeSciences Holdings Corporation
- Stryker Corporation
- Abbott Laboratories
- Terumo Corporation
- Johnson & Johnson
- Medtronic
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Component
4.2. Hardware
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Software
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Services
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Augmented Reality
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Virtual Reality
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Research Institutions
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Diagnostic Centers
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Clinics
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Component
7.2.3. Market Size and Forecast, By Technology
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Virtual and Augmented Reality in Healthcare Market
7.2.6.1. Market Size and Forecast, By Component
7.2.6.2. Market Size and Forecast, By Technology
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Virtual and Augmented Reality in Healthcare Market
7.2.7.1. Market Size and Forecast, By Component
7.2.7.2. Market Size and Forecast, By Technology
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Virtual and Augmented Reality in Healthcare Market
7.2.8.1. Market Size and Forecast, By Component
7.2.8.2. Market Size and Forecast, By Technology
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Component
7.3.3. Market Size and Forecast, By Technology
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Virtual and Augmented Reality in Healthcare Market
7.3.6.1. Market Size and Forecast, By Component
7.3.6.2. Market Size and Forecast, By Technology
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Virtual and Augmented Reality in Healthcare Market
7.3.7.1. Market Size and Forecast, By Component
7.3.7.2. Market Size and Forecast, By Technology
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Virtual and Augmented Reality in Healthcare Market
7.3.8.1. Market Size and Forecast, By Component
7.3.8.2. Market Size and Forecast, By Technology
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Virtual and Augmented Reality in Healthcare Market
7.3.9.1. Market Size and Forecast, By Component
7.3.9.2. Market Size and Forecast, By Technology
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Virtual and Augmented Reality in Healthcare Market
7.3.10.1. Market Size and Forecast, By Component
7.3.10.2. Market Size and Forecast, By Technology
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Virtual and Augmented Reality in Healthcare Market
7.3.11.1. Market Size and Forecast, By Component
7.3.11.2. Market Size and Forecast, By Technology
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Component
7.4.3. Market Size and Forecast, By Technology
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Virtual and Augmented Reality in Healthcare Market
7.4.6.1. Market Size and Forecast, By Component
7.4.6.2. Market Size and Forecast, By Technology
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Virtual and Augmented Reality in Healthcare Market
7.4.7.1. Market Size and Forecast, By Component
7.4.7.2. Market Size and Forecast, By Technology
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Virtual and Augmented Reality in Healthcare Market
7.4.8.1. Market Size and Forecast, By Component
7.4.8.2. Market Size and Forecast, By Technology
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Virtual and Augmented Reality in Healthcare Market
7.4.9.1. Market Size and Forecast, By Component
7.4.9.2. Market Size and Forecast, By Technology
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Virtual and Augmented Reality in Healthcare Market
7.4.10.1. Market Size and Forecast, By Component
7.4.10.2. Market Size and Forecast, By Technology
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Virtual and Augmented Reality in Healthcare Market
7.4.11.1. Market Size and Forecast, By Component
7.4.11.2. Market Size and Forecast, By Technology
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Component
7.5.3. Market Size and Forecast, By Technology
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Virtual and Augmented Reality in Healthcare Market
7.5.6.1. Market Size and Forecast, By Component
7.5.6.2. Market Size and Forecast, By Technology
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Virtual and Augmented Reality in Healthcare Market
7.5.7.1. Market Size and Forecast, By Component
7.5.7.2. Market Size and Forecast, By Technology
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Virtual and Augmented Reality in Healthcare Market
7.5.8.1. Market Size and Forecast, By Component
7.5.8.2. Market Size and Forecast, By Technology
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Virtual and Augmented Reality in Healthcare Market
7.5.9.1. Market Size and Forecast, By Component
7.5.9.2. Market Size and Forecast, By Technology
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. CAE
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. GE Healthcare
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Koninklijke Philips N.V.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Intuitive Surgical, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Siemens Ltd
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Eon Reality, Inc
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Bioflight VR
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. WorldViz
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. TheraSim Inc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. MindMaze
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 2. VASCULAR SEALING MEDICAL GLUE MARKET FOR REVASCULARIZATION, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. VASCULAR SEALING MEDICAL GLUE MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 5. VASCULAR SEALING MEDICAL GLUE MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. VASCULAR SEALING MEDICAL GLUE MARKET FOR SPECIALTY CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. VASCULAR SEALING MEDICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. VASCULAR SEALING MEDICAL GLUE MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. NORTH AMERICA VASCULAR SEALING MEDICAL GLUE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 10. NORTH AMERICA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 12. U.S. VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 13. U.S. VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 14. CANADA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 15. CANADA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 16. MEXICO VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 17. MEXICO VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 19. EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 21. GERMANY VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 22. GERMANY VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. FRANCE VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 24. FRANCE VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 25. UK VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 26. UK VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. ITALY VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 28. ITALY VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. SPAIN VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 30. SPAIN VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 31. REST OF EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 32. REST OF EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 34. ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. JAPAN VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 37. JAPAN VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 38. CHINA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 39. CHINA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. AUSTRALIA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 41. AUSTRALIA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. INDIA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 43. INDIA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 44. SOUTH KOREA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 45. SOUTH KOREA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. REST OF ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 47. REST OF ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 49. LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 51. BRAZIL VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 52. BRAZIL VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. SAUDI ARABIA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 54. SAUDI ARABIA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. SOUTH AFRICA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 56. SOUTH AFRICA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. REST OF LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 58. REST OF LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 60. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 61. BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
TABLE 62. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 63. BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 65. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 66. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 67. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 68. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69. ARTIVION, INC.: KEY EXECUTIVES
TABLE 70. ARTIVION, INC.: COMPANY SNAPSHOT
TABLE 71. ARTIVION, INC.: OPERATING SEGMENTS
TABLE 72. ARTIVION, INC.: PRODUCT PORTFOLIO
TABLE 73. ARTIVION, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. SUCCESS BIO-TECH: KEY EXECUTIVES
TABLE 75. SUCCESS BIO-TECH: COMPANY SNAPSHOT
TABLE 76. SUCCESS BIO-TECH: OPERATING SEGMENTS
TABLE 77. SUCCESS BIO-TECH: PRODUCT PORTFOLIO
TABLE 78. SUCCESS BIO-TECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 80. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 81. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 82. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 83. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 85. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 86. STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 87. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 88. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 90. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 91. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 92. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 93. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 95. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 96. TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 97. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 98. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 100. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 101. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 102. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 103. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. MEDTRONIC: KEY EXECUTIVES
TABLE 105. MEDTRONIC: COMPANY SNAPSHOT
TABLE 106. MEDTRONIC: OPERATING SEGMENTS
TABLE 107. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 108. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF VASCULAR SEALING MEDICAL GLUE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN VASCULAR SEALING MEDICAL GLUE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVASCULAR SEALING MEDICAL GLUE MARKET
FIGURE 10. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET SEGMENTATION, BY PROCEDURE
FIGURE 11. VASCULAR SEALING MEDICAL GLUE MARKET FOR REVASCULARIZATION, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. VASCULAR SEALING MEDICAL GLUE MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET SEGMENTATION, BY END USER
FIGURE 14. VASCULAR SEALING MEDICAL GLUE MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. VASCULAR SEALING MEDICAL GLUE MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. VASCULAR SEALING MEDICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 21. COMPETITIVE DASHBOARD
FIGURE 22. COMPETITIVE HEATMAP: VASCULAR SEALING MEDICAL GLUE MARKET
FIGURE 23. TOP PLAYER POSITIONING, 2023
FIGURE 24. BAXTER INTERNATIONAL INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. ARTIVION, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. ARTIVION, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. ARTIVION, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. SUCCESS BIO-TECH: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. SUCCESS BIO-TECH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. SUCCESS BIO-TECH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. STRYKER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. TERUMO CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security